中藥液經氧霧化吸入對慢性阻塞性肺疾病肺功能的影響及護理研究

摘 要 目的:探討中藥液經氧霧化吸入對慢性阻塞性肺疾病肺功能的影響及護理研究。方法:將入選80例慢性阻塞性肺疾病患者隨機分為治療組和對照組兩組。治療組在對照組治療基礎上加用中藥液15ml經氧霧化吸入2次/日，每次10～15分鐘，分別測定兩組治療前后第1秒用力肺活量(FEV1)，用力肺活量(FVC)及FEV1/FVC。結果:治療組FEV1、FVC，FEV1/EVC均明顯高于對照組。結論:中藥液經氧霧化吸入對COPD肺功能有改善作用。

關鍵詞 慢性阻塞性肺疾病 中藥液經氧霧化吸入 肺功能 臨床護理

doi:10.3969/j.issn.1007-614x.2010.22.259

AbstractObjective:To investigate the nursing research and effect of pulmonary function in the liquid of traditional chinese medicine atomizated by the oxygen inhalation in chronic obstructive pulmonary disease.Methods:80 patients with chronic obstructive pulmonary disease were randomly divided into treatment group and control group .The treatment group was added in 15ml the liquid of traditional chinese medicine atomizated by the oxygen inhalation 10～15 minutes per time，bid，on the basis of the control group.The forced vital capacity(FEV1)，forced vital capacity(FVC) and FEV1/FVC of the first second were measured in the two groups before and after treatment.Results FEV1 FVC，FEV1/EVC of the treatment group were significantly higher than the control group.Conclusion The liquid of traditional chinese medicine atomizated by the oxygen inhalation has improvement in pulmonary function of COPD.

Key Wordschronic obstructive pulmonary disease;the liquid of traditional chinese medicine atomizated by the oxygen inhalation;pulmonary function;nursing research

肺功能測定確定氣流受限有重要意義。在吸入支氣管舒張劑后，第1秒用力呼氣容積(FEV1)/用力肺活量(FVC)<70%，表明存在氣流受限，并且不能完全逆轉。肺功能檢查是判斷氣流受限的客觀指標，其重復性好，對COPD的診斷，嚴重程度評價，疾病進展，預后及治療反應等均有重要意義。COPD嚴重程度評估需根據患者的癥狀，肺功能異常，是否存在合并癥(呼吸衰竭、心力衰竭)等確定，其中反映氣流受阻程度的FEV1下降有重要參考意義，根據肺功能將COPD嚴重性分為Ⅰ級(輕度COPD)、Ⅱ級(中度COPD)、Ⅲ級(重度COPD)、Ⅳ級(極重度COPD)，FEV1%預計值對反映COPD嚴重程度健康狀況及病死率很重要[1]。霧化吸入療法是利用氣體射流原理，將水滴撞擊的微小霧滴懸浮于氣體中，形成氣霧劑而輸入呼吸道，以進行呼吸道濕化或藥物吸入的治療方法，作為全身治療的輔助和補充。霧化吸入療法直接作用于病變部位，與口服法相比具有用藥劑量小、見效快、不良反應少和使用方便等優點，且療效顯著。